As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the ‘epicenter’ of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe’s economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany’s GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China’s economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. published a report for global Veterinary Diagnostics market in this environment.
In terms of revenue, this research report indicated that the global Veterinary Diagnostics market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Veterinary Diagnostics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The ?IDEXX Laboratories aims at producing XX K Units Veterinary Diagnostics in 2020, with XX % production to take place in global market, ????Abaxis accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Veterinary Diagnostics Market by Include
- Southeast Asia
- South America
Competitive Analysis; Who are the Major Players in Veterinary Diagnostics Market?
- IDEXX Laboratories
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Shenzhen Mindray Bio-Medical Electronics
- NEOGEN CORPORATION
Major Type of Veterinary Diagnostics Covered in report:
- Molecular Diagnostics
- Clinical Chemistry
- Hematology Analyzers
- Diagnostic Imagining
Application Segments Covered in Market
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of content
Table of Contents
Global Veterinary Diagnostics Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Immunodiagnostics -Product Introduction and Major Manufacturers
1.1.2 Molecular Diagnostics -Product Introduction and Major Manufacturers
1.1.3 Clinical Chemistry -Product Introduction and Major Manufacturers
1.1.4 Hematology Analyzers -Product Introduction and Major Manufacturers
1.1.5 Diagnostic Imagining -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Veterinary Diagnostics Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Veterinary Diagnostics Market
3.1.1 Top Companies leading Veterinary Diagnostics Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Veterinary Diagnostics Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Veterinary Diagnostics Market
3.2.1 Top Companies leading Veterin
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/